Search clinical trials for: Trodusquemine (MSI-1436)

Total 5217 results

Genaera Corporation

Completed

An Ascending Multi-Dose, Tolerance and Pharmacokinetic Study in Obese or Overweight Type 2 Diabetic Volunteers

Obesity | Diabetes Mellitus

United States
Genaera Corporation

Completed

A Single Dose, Tolerance and Pharmacokinetic Study in Obese or Overweight Type 2 Diabetic Volunteers

Obesity | Diabetes Mellitus

United States
Northwell Health
DepYmed Inc.

Terminated

Safety and Tolerability of MSI-1436C in Metastatic Breast Cancer

Metastatic Breast Cancer

United States
Genaera Corporation

Completed

A Tolerance and Pharmacokinetic Study of Trodusquemine in Healthy Volunteers

Obesity

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study GSI-136 in Healthy Young and Healthy Elderly Subjects

Healthy | Alzheimer Disease

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Safety of GSI 136 in Young and Elderly Japanese Males

Healthy | Alzheimer Disease

Japan
Merck Sharp & Dohme LLC

Completed

Phase I Study of MK-1496 in Patients With Advanced Solid Tumor (MK-1496-002 AM 4)(COMPLETED)

Neoplasms | Malignant
MBX Biosciences
ProSciento, Inc.

Recruiting

Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of MBX 1416 in Healthy Subjects

Postbariatric Hypoglycemia

United States
Abide Therapeutics
CogState Ltd.; FGK Clinical Research GmbH; BASi (Bioanalytical Systems, Inc.)

Completed

Study of ABX-1431 in Adult Patients With Tourette Syndrome or Chronic Motor Tic Disorder

Tourette Syndrome | Motor Tic Disorder

Germany, Poland, Spain
Abide Therapeutics
University of Oxford

Completed

An fMRI Study in Healthy Volunteers to Investigate the Effects of ABX-1431 on Experimental Hyperalgesia and Its Neural Correlates

Pain

United Kingdom
Abide Therapeutics

Terminated

A Study to Evaluate the Effects of ABX-1431 on Patients With Functional Dyspepsia

Dyspepsia

Belgium
Abide Therapeutics

Completed

Central Pain Study for ABX-1431

Multiple Sclerosis | Neuromyelitis Optica Spectrum Disorder | Transverse Myelitis | Longitudinally Extensive Transverse Myelitis

United Kingdom
Abide Therapeutics

Completed

A Study to Evaluate the Effects of ABX-1431 on Patients With Tourette Syndrome

Tourette Syndrome | Chronic Motor Tic Disorder

Germany
Theravance Biopharma

Completed

Multiple Ascending Dose Study of TD-1439 in Healthy Adult and Elderly Subjects

Healthy Adults, Elderly Subjects

United States
Theravance Biopharma

Completed

Single Ascending Dose Study of TD-1439 in Healthy Subjects

Healthy Subjects

United States
Merck Sharp & Dohme LLC

Completed

A Study to Investigate the Influence of Hepatic Insufficiency on the Pharmacokinetics of Doravirine (MK-1439) (MK-1439-019)

HIV-1 Infection
H. Lundbeck A/S

Completed

Binding of Lu AG06466 in the Brain in Healthy Men

Healthy

Belgium
Mersana Therapeutics
IQVIA Biotech; PSI CRO

Terminated

Study of Upifitamab Rilsodotin in Combination With Carboplatin in Participants With High-grade Serous Ovarian Cancer (UPGRADE)

Platinum-sensitive Ovarian Cancer (UPGRADE-A)

United States
Merck Sharp & Dohme LLC

Completed

A Study Evaluating the Pharmacokinetics of Doravirine (MK-1439) in Participants With Severe Renal Impairment (MK-1439-051)

Renal Impairment
Centocor Research & Development, Inc.

Completed

A Study of the Safety and Pharmacokinetics of CNTO 136 in Patients With Cutaneous Lupus Erythematosus and Systemic Lupus Erythematosus

Lupus Erythematosus, Systemic | Lupus Erythematosus, Cutaneous
Mersana Therapeutics
IQVIA Biotech; PSI CRO

Recruiting

First-in-Human Study of XMT-1536 in Cancers Likely to Express NaPi2b

Platinum Resistant Ovarian Cancer | Non Small Cell Lung Cancer Metastatic

United States, Spain, United Kingdom, Australia, France, Austria, Belgium, Bulgaria, Canada, Czechia, Denmark, Finland, Hungary, Italy, Lithuania, New Zealand, Norway, Poland, Sweden
Abide Therapeutics

Completed

Titration Study of ABX-1431

Diabetic Peripheral Neuropathy | Small Fiber Neuropathy | Post Herpetic Neuralgia | Post-Traumatic Neuralgia

Moldova, Republic of
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Safety and Tolerability of SCA-136 in Healthy Japanese Male Subjects

Schizophrenia

Japan
AbbVie

Completed

Safety and Pharmacodynamic Study of ABT-436 in Major Depressive Disorder

Major Depressive Disorder
Taisho Pharmaceutical Co., Ltd.

Completed

Clinical Pharmacology Study of TS-143 in Nondialysis and Hemodialysis Patients With Chronic Kidney Disease

Chronic Kidney Disease

Japan
MEI Pharma, Inc.
Quotient Clinical

Completed

Assessment of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Various Formulations and Doses of PWT-143

Malignancies

United Kingdom
National Cancer Institute (NCI)

Completed

SJG-136 in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
National Cancer Institute (NCI)

Terminated

SJG-136 in Treating Patients With Relapsed or Refractory Acute Leukemia, Myelodysplastic Syndromes, Blastic Phase Chronic Myelogenous Leukemia, or Chronic Lymphocytic Leukemia

Recurrent Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) | Secondary Acute Myeloid Leukemia and other conditions

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Safety, PK and PD Study in Healthy Male Japanese Subjects

Schizophrenia
Wyeth is now a wholly owned subsidiary of Pfizer

Terminated

Study Evaluating SCA-136 Tolerability With Dose Titration and Food

Healthy

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Safety and Tolerability of SCA-136 in Healthy Japanese and Non-Japanese Female Subjects

Schizophrenia

United States
Fusion Pharmaceuticals Inc.

Recruiting

A Phase 1/2 Study of [225Ac]-FPI-1434 Injection

Cervical Cancer | Breast Cancer | Ovarian Cancer | Endometrial Cancer | Uveal Melanoma | Adrenocortical Carcinoma | Advanced Solid Tumours | HER2-negative Breast Cancer | Triple Negative Breast Cancer (TNBC) | Head and Neck Squamous Cell Carcinoma (HNSCC)

United States, Australia, Canada
Taisho Pharmaceutical Co., Ltd.

Completed

Clinical Study of TS-143 in Healthy Adult Male Subjects (Single-Dose Administration)

Healthy Participants

Japan
Taisho Pharmaceutical Co., Ltd.

Completed

Clinical Study of TS-143 in Healthy Adult Male Subjects (Multiple-Dose Administration)

Healthy Participants

Japan
Abbott

Completed

A Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of ABT-436 in Healthy Adults

Healthy

United States
Wayne State University

Terminated

Mobile Phone Application Versus Handheld Device for Fetal Vibroacoustic Stimulation

Pregnancy

United States
NeuShen Therapeutics

Not yet recruiting

First-into-human Study of NS-136 in Healthy Subjects

Healthy Subjects

Australia
Stanford University
GE Healthcare

Recruiting

PET/MRI in the Diagnosis of Chronic Pain

Radiculopathy | Neuropathic Pain | Myelopathy | Nociceptive Pain | Spinal Pain | Neurogenic Claudication | Mixed Pain (Nociceptive and Neuropathic)

United States
Merck Sharp & Dohme LLC

Completed

A Study of Doravirine (MK-1439) in Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Participants (MK-1439-005)

HIV-1 Infection
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Magnetic Resonance Imaging and Spectroscopy of the Prostate

Prostate Cancer

United States
Davidzon, Guido, M.D.

Terminated

18F-FTC-146 PET/CT in Newly-Diagnosed Osteosarcoma

Osteosarcoma

United States
Stanford University
GE Healthcare

Enrolling by invitation

PET/MRI in the Diagnosis of Pediatric Chronic Pain

Chronic Pain | Neuropathic Pain | Pediatric Disorder | Nociceptive Pain

United States
Merck Sharp & Dohme LLC

Recruiting

Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Ages 4 Weeks to <12 Years and <45 kg (MK-1439-066)

Human Immunodeficiency Virus (HIV) Infection

United States, Mexico, Russian Federation, South Africa, Thailand
Theralase® Technologies Inc.
University Health Network, Toronto; Pharma eMarket

Recruiting

Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients

Non-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCG

United States, Canada
Crown Laboratories, Inc.

Completed

A Six Week Topical Cream Study for Subjects With Ichthyosis Vulgaris

Ichthyosis Vulgaris

United States
Guido A. Davidzon, MD, SM

Withdrawn

Novel Clinical Target in Fragile X Syndrome

Fragile X Syndrome (FXS)

United States
MEI Pharma, Inc.
SCRI Development Innovations, LLC

Completed

Phase I Dose Escalation Study of the Safety and Pharmacokinetics of ME-143 Single Agent for Refractory Solid Tumors

Solid Tumors

United States
Laboratorios Sophia S.A de C.V.

Withdrawn

Safety and Tolerability of PRO-143 Ophthalmic Solution in Healthy Volunteers. (PRO-143)

Conjunctivitis, Bacterial

Mexico
Centocor, Inc.

Completed

A Study of the Safety and How the Body Effects a Drug CNTO 136 in Healthy Male Japanese and Caucasian Volunteers

Healthy
Alkermes, Inc.

Completed

ALK37-003: A Study of RDC-1036 (ALKS 37) in Adults With Opioid-induced Constipation (OIC)

Opioid-induced Constipation

United States

Search clinical trials for: Trodusquemine (MSI-1436)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United States

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations